EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Berberine as a Multi‐Targeted Therapeutic Agent in Melanoma: Mechanisms, Efficacy, and Combination Therapies

Rong-Rong Wang iD, Hui Wu, Meng-Ling Feng, Jia-Li Zhong, Rui-Xi Li, Bo-Xuan Zhou

Drug Development Research · 2025

DOI: 10.1002/ddr.70144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, 2025. Verfasst von Rong-Rong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Disease Center, the First Affiliated Hospital of Nanchang University, the First Clinical Medical College of Nanchang University,…. Hauptthemen laut MEDLINE: Berberine, Melanoma, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: This study was supported in part by the Natural Science Foundation of Jiangxi Province Youth Project (20242BAB20404), Jiangxi Province 'Ganpo Talent Program' i….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is a type of aggressive cancer distinguished by its high propensity for recurrence, the development of metastases, and an unfavorable outlook for recovery. Treatment modalities for melanoma encompass surgery, immunotherapy, and targeted therapies. In recent decades, berberine has garnered attention for its significant anticancer properties across various cancer types. This review systematically examines the molecular mechanisms of berberine in melanoma, particularly its modulation of critical signaling pathways, including B‐RAF/MEK/ERK, PI3K/AKT, and NF‐κB, which are essential for regulating melanoma cell proliferation and promoting apoptosis. Furthermore, berberine activates AMP‐activated protein kinase, leading to the inhibition of cyclooxygenase‐2, thereby reducing melanoma cell migration and invasion through decreased inflammation and enhanced cellular energy regulation. It also induces mitochondrial dysfunction and oxidative stress, promoting apoptosis while simultaneously inhibiting epithelial‐to‐mesenchymal transition, a key process in metastasis. Additionally, berberine modulates the immune microenvironment through Toll‐like receptors, cytokine networks, and the regulation of various immune cells, thereby enhancing its antitumor effects. Recent studies have shown that the therapeutic effect of berberine is enhanced when used in combination with other therapies, especially immune checkpoint inhibitors, to improve antitumor immune responses. These findings highlight the potential of berberine as a multi‐targeted agent for the treatment of melanoma, providing an avenue for further clinical exploration and integration into therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineMelanomaAntineoplastic AgentsHumansAnimalsSignal TransductionApoptosisTumor MicroenvironmentMolecular Targeted Therapy

Stichwörter der Autor:innen

Berberineapoptosiscell cyclemelanomasignaling pathwaytherapy

Substanzen

BerberineAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Breast Disease Center, the First Affiliated Hospital of Nanchang University, the First Clinical Medical College of Nanchang University, Jiangxi Medical College, Nanchang, P.R. China.
  • Department of Hepatobiliary and Pancreatic Surgery, the Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, P.R. China.

ORCID-Profile: Rong-Rong Wang

Förderung

  • This study was supported in part by the Natural Science Foundation of Jiangxi Province Youth Project (20242BAB20404), Jiangxi Province 'Ganpo Talent Program' i…

Zitieren

APA

Wang, R. R., Wu, H., Feng, M. L., Zhong, J. L., Li, R. X., & Zhou, B. X. (2025). Berberine as a Multi‐Targeted Therapeutic Agent in Melanoma: Mechanisms, Efficacy, and Combination Therapies. Drug Development Research. https://doi.org/10.1002/ddr.70144

Vancouver

Wang RR, Wu H, Feng ML, Zhong JL, Li RX, Zhou BX. Berberine as a Multi‐Targeted Therapeutic Agent in Melanoma: Mechanisms, Efficacy, and Combination Therapies. Drug Development Research. 2025. doi:10.1002/ddr.70144

BibTeX
@article{Wang2025,
  author = {Wang, Rong-Rong and Wu, Hui and Feng, Meng-Ling and Zhong, Jia-Li and Li, Rui-Xi and Zhou, Bo-Xuan},
  title = {Berberine as a Multi‐Targeted Therapeutic Agent in Melanoma: Mechanisms, Efficacy, and Combination Therapies},
  journal = {Drug Development Research},
  year = {2025},
  doi = {10.1002/ddr.70144}
}
Kostenlos starten →